IBDEI0LU ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27628,0)
 ;;=T50.901A^^74^1177^16
 ;;^UTILITY(U,$J,358.3,27628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27628,1,3,0)
 ;;=3^Poisoning by Drug/Meds/Bio Subst,Accidental,Init
 ;;^UTILITY(U,$J,358.3,27628,1,4,0)
 ;;=4^T50.901A
 ;;^UTILITY(U,$J,358.3,27628,2)
 ;;=^5052148
 ;;^UTILITY(U,$J,358.3,27629,0)
 ;;=G93.3^^74^1177^17
 ;;^UTILITY(U,$J,358.3,27629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27629,1,3,0)
 ;;=3^Postviral Fatigue Syndrome
 ;;^UTILITY(U,$J,358.3,27629,1,4,0)
 ;;=4^G93.3
 ;;^UTILITY(U,$J,358.3,27629,2)
 ;;=^5004181
 ;;^UTILITY(U,$J,358.3,27630,0)
 ;;=R53.1^^74^1177^20
 ;;^UTILITY(U,$J,358.3,27630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27630,1,3,0)
 ;;=3^Weakness
 ;;^UTILITY(U,$J,358.3,27630,1,4,0)
 ;;=4^R53.1
 ;;^UTILITY(U,$J,358.3,27630,2)
 ;;=^5019516
 ;;^UTILITY(U,$J,358.3,27631,0)
 ;;=I48.0^^74^1178^2
 ;;^UTILITY(U,$J,358.3,27631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27631,1,3,0)
 ;;=3^Proxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,27631,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,27631,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,27632,0)
 ;;=R55.^^74^1178^3
 ;;^UTILITY(U,$J,358.3,27632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27632,1,3,0)
 ;;=3^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,27632,1,4,0)
 ;;=4^R55.
 ;;^UTILITY(U,$J,358.3,27632,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,27633,0)
 ;;=I48.1^^74^1178^1
 ;;^UTILITY(U,$J,358.3,27633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27633,1,3,0)
 ;;=3^Persistant Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,27633,1,4,0)
 ;;=4^I48.1
 ;;^UTILITY(U,$J,358.3,27633,2)
 ;;=^5007225
 ;;^UTILITY(U,$J,358.3,27634,0)
 ;;=G00.9^^74^1179^3
 ;;^UTILITY(U,$J,358.3,27634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27634,1,3,0)
 ;;=3^Bacterial Meningitis,Unspec
 ;;^UTILITY(U,$J,358.3,27634,1,4,0)
 ;;=4^G00.9
 ;;^UTILITY(U,$J,358.3,27634,2)
 ;;=^5003724
 ;;^UTILITY(U,$J,358.3,27635,0)
 ;;=G04.00^^74^1179^1
 ;;^UTILITY(U,$J,358.3,27635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27635,1,3,0)
 ;;=3^Acute Disseminated Encephalitis/Encephalomyelitis,Unspec
 ;;^UTILITY(U,$J,358.3,27635,1,4,0)
 ;;=4^G04.00
 ;;^UTILITY(U,$J,358.3,27635,2)
 ;;=^5003730
 ;;^UTILITY(U,$J,358.3,27636,0)
 ;;=G04.90^^74^1179^5
 ;;^UTILITY(U,$J,358.3,27636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27636,1,3,0)
 ;;=3^Encephalitis/Encephalomyelitis,Unspec
 ;;^UTILITY(U,$J,358.3,27636,1,4,0)
 ;;=4^G04.90
 ;;^UTILITY(U,$J,358.3,27636,2)
 ;;=^5003741
 ;;^UTILITY(U,$J,358.3,27637,0)
 ;;=G35.^^74^1179^7
 ;;^UTILITY(U,$J,358.3,27637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27637,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,27637,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,27637,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,27638,0)
 ;;=G36.0^^74^1179^8
 ;;^UTILITY(U,$J,358.3,27638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27638,1,3,0)
 ;;=3^Neuromyelitis Optica
 ;;^UTILITY(U,$J,358.3,27638,1,4,0)
 ;;=4^G36.0
 ;;^UTILITY(U,$J,358.3,27638,2)
 ;;=^5003817
 ;;^UTILITY(U,$J,358.3,27639,0)
 ;;=G37.3^^74^1179^2
 ;;^UTILITY(U,$J,358.3,27639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27639,1,3,0)
 ;;=3^Acute Transverse Myelitis in Demyelinating Disease of CNSL
 ;;^UTILITY(U,$J,358.3,27639,1,4,0)
 ;;=4^G37.3
 ;;^UTILITY(U,$J,358.3,27639,2)
 ;;=^5003824
 ;;^UTILITY(U,$J,358.3,27640,0)
 ;;=G61.0^^74^1179^6
 ;;^UTILITY(U,$J,358.3,27640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27640,1,3,0)
 ;;=3^Guillain-Barre Syndrome
 ;;^UTILITY(U,$J,358.3,27640,1,4,0)
 ;;=4^G61.0
 ;;^UTILITY(U,$J,358.3,27640,2)
 ;;=^53405
 ;;^UTILITY(U,$J,358.3,27641,0)
 ;;=G61.81^^74^1179^4
 ;;^UTILITY(U,$J,358.3,27641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27641,1,3,0)
 ;;=3^Chronic Inflammatory Demyelinating Polyneuritis
 ;;^UTILITY(U,$J,358.3,27641,1,4,0)
 ;;=4^G61.81
 ;;^UTILITY(U,$J,358.3,27641,2)
 ;;=^328480
 ;;^UTILITY(U,$J,358.3,27642,0)
 ;;=D86.81^^74^1179^9
 ;;^UTILITY(U,$J,358.3,27642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27642,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,27642,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,27642,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,27643,0)
 ;;=G51.0^^74^1180^2
 ;;^UTILITY(U,$J,358.3,27643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27643,1,3,0)
 ;;=3^Bell's Palsy
 ;;^UTILITY(U,$J,358.3,27643,1,4,0)
 ;;=4^G51.0
 ;;^UTILITY(U,$J,358.3,27643,2)
 ;;=^13238
 ;;^UTILITY(U,$J,358.3,27644,0)
 ;;=G54.0^^74^1180^3
 ;;^UTILITY(U,$J,358.3,27644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27644,1,3,0)
 ;;=3^Brachial Plexus Disorders
 ;;^UTILITY(U,$J,358.3,27644,1,4,0)
 ;;=4^G54.0
 ;;^UTILITY(U,$J,358.3,27644,2)
 ;;=^5004007
 ;;^UTILITY(U,$J,358.3,27645,0)
 ;;=G56.00^^74^1180^4
 ;;^UTILITY(U,$J,358.3,27645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27645,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Unspec Upper Limb
 ;;^UTILITY(U,$J,358.3,27645,1,4,0)
 ;;=4^G56.00
 ;;^UTILITY(U,$J,358.3,27645,2)
 ;;=^5004017
 ;;^UTILITY(U,$J,358.3,27646,0)
 ;;=G56.20^^74^1180^14
 ;;^UTILITY(U,$J,358.3,27646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27646,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Unspec Upper Limb
 ;;^UTILITY(U,$J,358.3,27646,1,4,0)
 ;;=4^G56.20
 ;;^UTILITY(U,$J,358.3,27646,2)
 ;;=^5004023
 ;;^UTILITY(U,$J,358.3,27647,0)
 ;;=G56.90^^74^1180^18
 ;;^UTILITY(U,$J,358.3,27647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27647,1,3,0)
 ;;=3^Mononeuropathy,Unspec Upper Limb
 ;;^UTILITY(U,$J,358.3,27647,1,4,0)
 ;;=4^G56.90
 ;;^UTILITY(U,$J,358.3,27647,2)
 ;;=^5004035
 ;;^UTILITY(U,$J,358.3,27648,0)
 ;;=G57.00^^74^1180^13
 ;;^UTILITY(U,$J,358.3,27648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27648,1,3,0)
 ;;=3^Lesion Sciatic Nerve,Unspec Lower Limb
 ;;^UTILITY(U,$J,358.3,27648,1,4,0)
 ;;=4^G57.00
 ;;^UTILITY(U,$J,358.3,27648,2)
 ;;=^5004038
 ;;^UTILITY(U,$J,358.3,27649,0)
 ;;=G57.10^^74^1180^15
 ;;^UTILITY(U,$J,358.3,27649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27649,1,3,0)
 ;;=3^Meralgia Paresthetica,Unspec Lower Limb
 ;;^UTILITY(U,$J,358.3,27649,1,4,0)
 ;;=4^G57.10
 ;;^UTILITY(U,$J,358.3,27649,2)
 ;;=^5004041
 ;;^UTILITY(U,$J,358.3,27650,0)
 ;;=G57.90^^74^1180^17
 ;;^UTILITY(U,$J,358.3,27650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27650,1,3,0)
 ;;=3^Mononeuropathy,Unspec Lower Limb
 ;;^UTILITY(U,$J,358.3,27650,1,4,0)
 ;;=4^G57.90
 ;;^UTILITY(U,$J,358.3,27650,2)
 ;;=^5004061
 ;;^UTILITY(U,$J,358.3,27651,0)
 ;;=G58.7^^74^1180^16
 ;;^UTILITY(U,$J,358.3,27651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27651,1,3,0)
 ;;=3^Mononeuritis Multiplex
 ;;^UTILITY(U,$J,358.3,27651,1,4,0)
 ;;=4^G58.7
 ;;^UTILITY(U,$J,358.3,27651,2)
 ;;=^5004063
 ;;^UTILITY(U,$J,358.3,27652,0)
 ;;=G60.0^^74^1180^8
 ;;^UTILITY(U,$J,358.3,27652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27652,1,3,0)
 ;;=3^Hereditary Motor & Sensory Neuropathy
 ;;^UTILITY(U,$J,358.3,27652,1,4,0)
 ;;=4^G60.0
 ;;^UTILITY(U,$J,358.3,27652,2)
 ;;=^5004067
 ;;^UTILITY(U,$J,358.3,27653,0)
 ;;=G60.3^^74^1180^9
 ;;^UTILITY(U,$J,358.3,27653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27653,1,3,0)
 ;;=3^Idiopathic Progressive Neuropathy
 ;;^UTILITY(U,$J,358.3,27653,1,4,0)
 ;;=4^G60.3
 ;;^UTILITY(U,$J,358.3,27653,2)
 ;;=^5004069
 ;;^UTILITY(U,$J,358.3,27654,0)
 ;;=G62.0^^74^1180^7
 ;;^UTILITY(U,$J,358.3,27654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27654,1,3,0)
 ;;=3^Drug-Induced Polyneuropathy
 ;;^UTILITY(U,$J,358.3,27654,1,4,0)
 ;;=4^G62.0
 ;;^UTILITY(U,$J,358.3,27654,2)
 ;;=^5004075
 ;;^UTILITY(U,$J,358.3,27655,0)
 ;;=G62.1^^74^1180^1
 ;;^UTILITY(U,$J,358.3,27655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27655,1,3,0)
 ;;=3^Alcoholic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,27655,1,4,0)
 ;;=4^G62.1
 ;;^UTILITY(U,$J,358.3,27655,2)
 ;;=^5004076
 ;;^UTILITY(U,$J,358.3,27656,0)
 ;;=G63.^^74^1180^21
 ;;^UTILITY(U,$J,358.3,27656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27656,1,3,0)
 ;;=3^Polyneuropathy in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,27656,1,4,0)
 ;;=4^G63.
 ;;^UTILITY(U,$J,358.3,27656,2)
 ;;=^5004080
 ;;^UTILITY(U,$J,358.3,27657,0)
 ;;=G70.00^^74^1180^20
 ;;^UTILITY(U,$J,358.3,27657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27657,1,3,0)
 ;;=3^Myasthenia Gravis w/o Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,27657,1,4,0)
 ;;=4^G70.00
 ;;^UTILITY(U,$J,358.3,27657,2)
 ;;=^329920
 ;;^UTILITY(U,$J,358.3,27658,0)
 ;;=G70.01^^74^1180^19
 ;;^UTILITY(U,$J,358.3,27658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27658,1,3,0)
 ;;=3^Myasthenia Gravis w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,27658,1,4,0)
 ;;=4^G70.01
 ;;^UTILITY(U,$J,358.3,27658,2)
 ;;=^329921
 ;;^UTILITY(U,$J,358.3,27659,0)
 ;;=G70.80^^74^1180^12
 ;;^UTILITY(U,$J,358.3,27659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27659,1,3,0)
 ;;=3^Lambert-Eaton Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,27659,1,4,0)
 ;;=4^G70.80
 ;;^UTILITY(U,$J,358.3,27659,2)
 ;;=^340608
 ;;^UTILITY(U,$J,358.3,27660,0)
 ;;=G72.0^^74^1180^6
 ;;^UTILITY(U,$J,358.3,27660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27660,1,3,0)
 ;;=3^Drug-Induced Myopathy
 ;;^UTILITY(U,$J,358.3,27660,1,4,0)
 ;;=4^G72.0
 ;;^UTILITY(U,$J,358.3,27660,2)
 ;;=^5004095
 ;;^UTILITY(U,$J,358.3,27661,0)
 ;;=G72.41^^74^1180^10
 ;;^UTILITY(U,$J,358.3,27661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27661,1,3,0)
 ;;=3^Inclusion Body Myositis
 ;;^UTILITY(U,$J,358.3,27661,1,4,0)
 ;;=4^G72.41
 ;;^UTILITY(U,$J,358.3,27661,2)
 ;;=^5004098
 ;;^UTILITY(U,$J,358.3,27662,0)
 ;;=G72.49^^74^1180^11
 ;;^UTILITY(U,$J,358.3,27662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27662,1,3,0)
 ;;=3^Inflammatory & Immune Myopathies NEC
 ;;^UTILITY(U,$J,358.3,27662,1,4,0)
 ;;=4^G72.49
 ;;^UTILITY(U,$J,358.3,27662,2)
 ;;=^5004099
 ;;^UTILITY(U,$J,358.3,27663,0)
 ;;=E11.40^^74^1180^5
 ;;^UTILITY(U,$J,358.3,27663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27663,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,27663,1,4,0)
 ;;=4^E11.40
